PRM15 - The American Society of Clinical Oncology (Asco) Net Health Benefit (Nhb) Assessment Tool: Which Implications for Value Assessment of Cancer Therapies?
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2016 Published by Elsevier Inc.